Glimisave MV 1.3 10 tab

Glimisave MV 1.3 from Eris Lifesciences is a triple-action diabetes tablet with Glimepiride, Metformin and a higher dose of Voglibose. It is prescribed for adults with type 2 diabetes who have sharp sugar spikes after meals.

• Type 2 diabetes in adults
• To control sharp after-meal sugar spikes
• When standard combinations are not enough

Glimepiride encourages the pancreas to release more insulin. Metformin reduces sugar made by the liver and improves the body's response to insulin. The higher Voglibose dose strongly slows breakdown of carbohydrates in the gut, smoothing post-meal sugar rises.

Take as prescribed by your doctor. Swallow with the very first bite of the main meal so Voglibose works on the meal. Maintain regular meal times.

• Low blood sugar
• Increased gas, bloating, soft stools
• Stomach discomfort
• Metallic taste
• Weight changes

Avoid in severe kidney or liver disease and bowel problems. Treat low sugar with glucose, not table sugar. Avoid alcohol. Have regular sugar, kidney and liver tests.

Store below 25°C in a cool, dry place away from sunlight and moisture. Keep in original strip and out of children's reach.